×
About 258 results

ALLMedicine™ Pulmonary Eosinophilia Center

Research & Reviews  95 results

Drug-related pneumonitis induced by osimertinib as first-line treatment for EGFR-positi...
https://doi.org/10.1016/j.chest.2022.05.035
Chest Sato Y, Sumikawa H et. al.

Jun 7th, 2022 - Osimertinib has demonstrated impressive efficacy as a first-line treatment for patients with advanced epidermal growth factor receptor (EGFR) mutation-positive (m+) lung cancer. Drug-related pneumonitis (DRP) is a potentially lethal complication o...

Loffler Syndrome
https://emedicine.medscape.com/article/1002606-overview

Apr 14th, 2022 - Practice Essentials Löffler syndrome is a transient respiratory illness associated with blood eosinophilia and radiographic shadowing. (See the image below.) It was initially described by Löffler in 1932. In 1952, Crofton included Löffler syndrome...

Loffler Syndrome
https://emedicine.medscape.com/article/1002606-print

Apr 14th, 2022 - Practice Essentials Löffler syndrome is a transient respiratory illness associated with blood eosinophilia and radiographic shadowing. (See the image below.) It was initially described by Löffler in 1932. In 1952, Crofton included Löffler syndrome...

Loffler Syndrome Clinical Presentation
https://emedicine.medscape.com/article/1002606-clinical

Apr 14th, 2022 - History Symptoms of Löffler syndrome are usually mild or absent and tend to spontaneously resolve after several days or, at most, after 2-3 weeks. Cough is the most common symptom among symptomatic patients. It is usually dry and unproductive but ...

Loffler Syndrome Medication
https://emedicine.medscape.com/article/1002606-medication

Apr 14th, 2022 - Medication Summary The minimal nature of symptoms in most patients with Löffler syndrome usually denotes that no pharmacologic therapy is required for this self-limiting condition. For drug-induced pulmonary eosinophilia, discontinue administratio...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  1 results

Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin
https://clinicaltrials.gov/ct2/show/NCT04414137

Nov 9th, 2020 - Daptomycin is an antibiotic from the family of cyclic lipopeptides, bactericide, concentration-dependent. Its spectrum concerns Gram-positive bacteria. The Infectious Diseases Society of America recommends the use of daptomycin 6 mg / kg / day in ...

see more →

News  3 results

FDA OKs First Generic of Daraprim (Pyrimethamine) Tablets
https://www.medscape.com/viewarticle/925980

Mar 2nd, 2020 - The US Food and Drug Administration (FDA) has approved the first generic version of the antiparasitic drug Daraprim (pyrimethamine) for the treatment of toxoplasmosis when used with a sulfonamide. The generic version of Daraprim tablets is made by...

ICD-10 codes for EVALI released
https://www.mdedge.com/chestphysician/article/211044/pulmonology/icd-10-codes-evali-released
Gregory Twachtman, MDedge News

Oct 28th, 2019 - The Centers for Disease Control and Prevention has issued coding guidance to help track e-cigarette, or vaping, product use–associated lung injury (EVALI). mauro grigollo/Thinkstock The purpose of the coding guidelines “is to provide official diag.

GIs in Iraq Got Rare Pneumonia
https://www.mdedge.com/familymedicine/article/25055/infectious-diseases/gis-iraq-got-rare-pneumonia
Family Practice News; Sharon Worcester

Acute eosinophilic pneumonia is considered a rare disease, but it occurred at an increased rate among a population of soldiers serving in or near Iraq between March 2003 and March 2004, and may be associated with new-onset smoking and/or dust inha.

see more →